Re: Farmas USA
Re: Farmas USA
Re: Farmas USA
Que cansinas son las SNTA....
Y las AMRN, ni os cuento....
Edito: se han adentrado en el gap las AMRN......
Un saludo
Re: Farmas USA
NBY
Todo muy bonito, pero el articulista ve peligro de dilución.
" As of March 31st, the company had cash and equivalents of $13.2 million relative to $16.9 million as of December 31st 2012. With licensing and collaboration revenue of $0.9 million in Q1, the company did note that it "did not recognize any other significant revenues for the three months ended March 31, 2013," confirming my concerns about the actual marketability of NeutroPhase by the company and indicating a need for some type of collaboration or marketing agreement in order to get the treatment off the ground and generating revenue.
I would anticipate a Q4 2013 or Q1 2014 financing of some type."